Concepedia

Publication | Open Access

Efficacy and safety of once-daily, single-inhaler fluticasone furoate/umeclidinium/vilanterol versus fluticasone furoate/vilanterol in Japanese patients with inadequately controlled asthma: the CAPTAIN study

DOIFull Paper Access

12

Citations

15

References

2021

Year

Yoichi Nakamura, Soichiro Hozawa, Hironori Sagara, Hiroyuki Ohbayashi, Laurie A. Lee, Jodie Crawford, Jun Tamaoki, Takanobu Nishi, Andrew Fowler
Current Medical Research and Opinion

Abstract

FF/UMEC/VI is an effective option with a favorable risk-benefit profile in Japanese patients with uncontrolled moderate or severe asthma on ICS/LABA.

References

YearCitations

Page 1